Review question / Objective: The aim of the systematic review and meta-analysis is to evaluate the efficacy and safety of dienogest in the treatment of women with symptoms ascribed to endometriosis or adenomyosis. Condition being studied: E…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…
The IL-6 levels in serum obtained from 28 AM patients and 24 gynecological benign disease controls and 15 normal controls were determined by ELISA. Il-6 in patients with adenomysis (99.06±61.30pg/ml) was significantly higher than that in co…